题目内容
急性淋巴细胞白血病维持治疗阶段的主要用药是
2021-11-24
A.地寨米松+阿糖胞苷
B.长春新碱+阿糖胞苷
C.甲氨蝶呤+地塞米松
D.甲氨蝶呤+硫鸟嘌呤
E.长春新碱+甲氨蝶呤
试卷相关题目
SQL Error: select id,body,options from ***_enewstiku where sourceid='28404' and id < 2320941 and id<>'2320941' order by id desc limit 5 SQL Error: select id,body,options from ***_enewstiku where sourceid='28404' and id > 2320941 and id<>'2320941' order by id asc limit 5